Amy K. ReeveAmy did her undergraduate degree
in Neuroscience at Edinburgh University before moving to the Mitochondrial
Research Group at Newcastle University for her PhD studies. She completed her PhD
in the study of the molecular mechanisms of neurodegenerative disease in 2007
and now has her own research group within the Wellcome Trust Centre for
Mitochondrial Research. Her current research interests centre around
understanding the mechanisms behind the neurodegeneration seen in Parkinson’s
disease, and the contribution of mitochondrial dysfunction to these changes.
Funded by Parkinson’s UK as a research fellow Amy’s interests lie in
understanding how changes within mitochondria, mitochondrial transport and the
interaction of mitochondrial with alpha-synuclein contributes to the
development of Parkinson’s disease. Eve M. SimcoxEve did her undergraduate degree
in Biomedical Science at Newcastle University and continued her studies within
the Mitochondrial Research Group for her PhD. She completed her PhD in the
study of the turnover and dynamics of mitochondria in neurodegenerative disease
in 2014 and now works as the impact officer for the faculty of Science,
Agriculture and Engineering. Michael R. DuchenMichael obtained his Bachelor of Medicine degree from Oxford
and London Universities, and moved to UCL for his PhD studies. He has remained
at UCL since, where he is now a Professor of Physiology. Michael founded and
leads the UCL consortium for Mitochondrial Research and leads a successful
research group. Michael's interests lie primarily in understanding the relationships
between mitochondrial biology and cell signalling. His research group's main
interest lies in understanding the inter-relationship between calcium
signalling, mitochondria and free radical biology in cell physiology and
pathophysiology. Particular contributions have been made into understanding the
contribution of mitochondrial dysfunction to cell injury and death.Doug M. TurnbullProfessor Turnbull is a clinical academic who leads a basic
science research programme in conjunction with developing clinical services. He
has three main roles.Director of the Wellcome Trust Centre for Mitochondrial
Research. The Wellcome Trust Centre is focused on research to improve the lives
of patients with mitochondrial disease. This includes research to identify the
genetic defect in patients with mitochondrial disease and his work also focuses
understanding the molecular mechanisms underlying the neurological features in
patients. With colleagues he is searching for new therapies for patients and actively
involved in clinical studies evaluating potential therapies. He has been
actively involved in work to prevent the transmission of mitochondrial DNA
disease using an IVF technique called mitochondrial donation.Lead for the NHS Highly Specialised Services for Rare
Mitochondrial Services for Adults and Children. Professor Turnbull developed
this service provides optimum care for patients with mitochondrial disease
throughout the UK with Centres in Newcastle, London and Oxford. This service
was built on the back of clinical and basic research and the service reviews in
excess of 800 patients per year. The service has developed care pathways and
patient guidance that are used worldwide of the benefit of patients.
Director MRC/BBSRC Centre for Ageing and Vitality. Professor
Turnbull has a major interest in understanding the basic mechanisms involved in
human ageing with particular emphasis on the role of mitochondria. The MRC
Centre is focused on understanding how these mechanisms are influenced by
lifestyle interventions and studies aimed at promoting healthy ageing.